News

Novartis Stock Rises After Swiss Drugmaker Promises to Boost U.S. Manufacturing
A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 ...
BioPharma Dive23h
Amid tariff turmoil, Novartis commits to spending $23B on US manufacturing
Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...
NJBIZ17h
Novartis investing $23B on US manufacturing, R&D buildup
Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.
Novartis leaves NC incentive as it lowers hiring target at Durham manufacturing site
The pharmaceutical company says it will continue to operate its production facility near Research Triangle Park.
Bisnow23h
Novartis Reveals $23B Plan To Boost U.S. Research And Manufacturing Presence
The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to ...
BioSpace1d
The 5 Largest Biopharma Layoffs of Q1 2025
The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...
Novartis Stock (NVS) Looks Healthier as it Spends $23B on Ramping Up U.S. Manufacturing
Shares in Swiss drugmaker Novartis (NVS) were looking perkier today as it set out plans to invest $23 billion in U.S. manufacturing to beat the ...
Prostate cancer drug now available to more patients with aggressive form of disease
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
Stocks to Watch Friday: JPMorgan, Novartis, BYD
Morgan Stanley (MS), and Wells Fargo (WFC) are expected to r ...